Our Team
Our Team
Inspirational Leadership Team and Expert Advisors Guiding Strategic Growth
Novadip’s highly experienced management team has a deep knowledge of science, regulation and development pathways, as well as a proven track record in significant fundraising for regenerative medicine companies. The team is committed to advancing our 3M3 tissue regeneration platform to accelerate healing through single treatment cures.
Executive Leadership Team
Denis Dufrane, MD, PhD
Co-Founder, Chief Executive Officer
& Board Member
Judy Ashworth, MD
Chief Medical Officer
Virginie Cartage
Chief Financial Officer
Hara Episkopou, PhD
VP R&D
Siegfried Ebner, PhD
Chief Operations Officer
Gaëtane Metz,
VP Quality
Justine Fourmeau
VP Clinical Manufacturing
Board of Directors
Eric Paul Pâques, PhD
Chairman
Gil Beyen, MBA
Independent Board Member
Jean-Pierre Bizet, PhD
New Science Ventures
Philippe Durieux
Vives Partners
Patrick Van Beneden
Jason Zhou, MBBS, MBA
China Resources
Christina Franssen, PhD
SRIW
Clinical & Scientific Advisory Board
Gunnar B. J. Andersson MD, PhD
Chairman, Clinical Advisory Board
Aaron W. James, MD, PhD
Chairman, Scientific Advisory Board
Our Science
Our Pipeline
Our robust pipeline of treatments is designed with patient need in mind—where can we make the most difference and help patients with devastating conditions impacting quality of life. We’re poised to make a difference in the lives of patients who are in need of spinal fusion surgeries, for those who have undergone tumor removal for cancers, difficult healing fractures, and more.